We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Biosimilar Insulin industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Rapid Acting Insulins
Short Acting Insulins
Intermediate Insulins
Long Lasting Insulins
Market Segment by Product Application
Hospital
Clinic
Medical Center
Finally, the report provides detailed profile and data information analysis of leading company.
Pfizer
Biogenomics
Eli Lilly
Gan&Lee Pharmaceuticals
Geropharm
Julphar Gulf Pharmaceutical Industries
Paras Biopharmaceuticals
Samsung Bioepis
Sedico
Wockhardt
Teva Pharmaceuticals
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Biosimilar Insulin consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Biosimilar Insulin market by identifying its various subsegments.
3.Focuses on the key global Biosimilar Insulin manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Biosimilar Insulin with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Biosimilar Insulin submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Biosimilar Insulin Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Biosimilar Insulin Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Biosimilar Insulin Segment by Type
2.1.1 Rapid Acting Insulins
2.1.2 Short Acting Insulins
2.1.3 Intermediate Insulins
2.1.4 Long Lasting Insulins
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Medical Center
2.3 Global Biosimilar Insulin Market Comparison by Regions (2017-2027)
2.3.1 Global Biosimilar Insulin Market Size (2017-2027)
2.3.2 North America Biosimilar Insulin Status and Prospect (2017-2027)
2.3.3 Europe Biosimilar Insulin Status and Prospect (2017-2027)
2.3.4 China Biosimilar Insulin Status and Prospect (2017-2027)
2.3.5 Japan Biosimilar Insulin Status and Prospect (2017-2027)
2.3.6 Southeast Asia Biosimilar Insulin Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Biosimilar Insulin Industry Impact
2.5.1 Biosimilar Insulin Business Impact Assessment - Covid-19
2.5.2 Market Trends and Biosimilar Insulin Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Biosimilar Insulin Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Biosimilar Insulin Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Biosimilar Insulin Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Biosimilar Insulin Manufacturer Market Share
3.5 Top 10 Biosimilar Insulin Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Biosimilar Insulin Market
3.7 Key Manufacturers Biosimilar Insulin Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Biosimilar Insulin Industry Key Manufacturers
4.1 Pfizer
4.1.1 Compan Detail
4.1.2 Pfizer Biosimilar Insulin Product Introduction, Application and Specification
4.1.3 Pfizer 162 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Pfizer News
4.2 Biogenomics
4.2.1 Compan Detail
4.2.2 Biogenomics Biosimilar Insulin Product Introduction, Application and Specification
4.2.3 Biogenomics Biosimilar Insulin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Pfizer News
4.3 Eli Lilly
4.3.1 Compan Detail
4.3.2 Eli Lilly Biosimilar Insulin Product Introduction, Application and Specification
4.3.3 Eli Lilly Biosimilar Insulin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Eli Lilly News
4.4 Gan&Lee Pharmaceuticals
4.4.1 Compan Detail
4.4.2 Gan&Lee Pharmaceuticals Biosimilar Insulin Product Introduction, Application and Specification
4.4.3 Gan&Lee Pharmaceuticals Biosimilar Insulin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Gan&Lee Pharmaceuticals News
4.5 Geropharm
4.5.1 Compan Detail
4.5.2 Gan&Lee Pharmaceuticals Biosimilar Insulin Product Introduction, Application and Specification
4.5.3 Geropharm Biosimilar Insulin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Geropharm News
4.6 Julphar Gulf Pharmaceutical Industries
4.6.1 Compan Detail
4.6.2 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Product Introduction, Application and Specification
4.6.3 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Julphar Gulf Pharmaceutical Industries News
4.7 Paras Biopharmaceuticals
4.7.1 Compan Detail
4.7.2 Paras Biopharmaceuticals Biosimilar Insulin Product Introduction, Application and Specification
4.7.3 Paras Biopharmaceuticals Biosimilar Insulin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Samsung Bioepis
4.8.1 Compan Detail
4.8.2 Samsung Bioepis Biosimilar Insulin Product Introduction, Application and Specification
4.8.3 Samsung Bioepis Biosimilar Insulin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Samsung Bioepis News
4.9 Sedico
4.9.1 Compan Detail
4.9.2 Sedico Biosimilar Insulin Product Introduction, Application and Specification
4.9.3 Sedico Biosimilar Insulin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Sedico News
4.10 Wockhardt
4.10.1 Compan Detail
4.10.2 Wockhardt Biosimilar Insulin Product Introduction, Application and Specification
4.10.3 Wockhardt Biosimilar Insulin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Wockhardt News
4.11 Teva Pharmaceuticals
4.11.1 Compan Detail
4.11.2 Teva Pharmaceuticals Biosimilar Insulin Product Introduction, Application and Specification
4.11.3 Teva Pharmaceuticals Biosimilar Insulin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Teva Pharmaceuticals News
5 Global Biosimilar Insulin Market Segment by Big Type
5.1 Global Biosimilar Insulin Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Biosimilar Insulin Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Biosimilar Insulin Revenue and Market Share by Big Type (2017-2022)
5.2 Rapid Acting Insulins Sales Growth Rate and Price
5.2.1 Global Rapid Acting Insulins Sales Growth Rate (2017-2022)
5.2.2 Global Rapid Acting Insulins Price (2017-2022)
5.3 Short Acting Insulins Sales Growth Rate and Price
5.3.1 Global Short Acting Insulins Sales Growth Rate (2017-2022)
5.3.2 Global Short Acting Insulins Price (2017-2022)
5.4 Intermediate Insulins Sales Growth Rate and Price
5.4.1 Global Intermediate Insulins Sales Growth Rate (2017-2022)
5.4.2 Global Intermediate Insulins Price (2017-2022)
5.5 Long Lasting Insulins Sales Growth Rate and Price
5.5.1 Global Long Lasting Insulins Sales Growth Rate (2017-2022)
5.5.2 Global Long Lasting Insulins Price (2017-2022)
6 Global Biosimilar Insulin Market Segment by Big Application
6.1 Global Biosimilar Insulin Sales Market Share by Big Application (2017-2022)
6.2 Hospital Sales Growth Rate (2017-2022)
6.3 Clinic Sales Growth Rate (2017-2022)
6.4 Medical Center Sales Growth Rate (2017-2022)
7 Global Biosimilar Insulin Forecast
7.1 Global Biosimilar Insulin Revenue, Sales and Growth Rate (2022-2027)
7.2 Biosimilar Insulin Market Forecast by Regions (2022-2027)
7.2.1 North America Biosimilar Insulin Market Forecast (2022-2027)
7.2.2 Europe Biosimilar Insulin Market Forecast (2022-2027)
7.2.3 China Biosimilar Insulin Market Forecast (2022-2027)
7.2.4 Japan Biosimilar Insulin Market Forecast (2022-2027)
7.2.5 Southeast Asia Biosimilar Insulin Market Forecast (2022-2027)
7.2.6 Other Regions Biosimilar Insulin Market Forecast (2022-2027)
7.3 Biosimilar Insulin Market Forecast by Type (2022-2027)
7.3.1 Global Biosimilar Insulin Sales Forecast by Type (2022-2027)
7.3.2 Global Biosimilar Insulin Market Share Forecast by Type (2022-2027)
7.4 Biosimilar Insulin Market Forecast by Application (2022-2027)
7.4.1 Global Biosimilar Insulin Sales Forecast by Application (2022-2027)
7.4.2 Global Biosimilar Insulin Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Biosimilar Insulin Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Biosimilar Insulin Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Biosimilar Insulin
Figure Market Concentration Ratio and Market Maturity Analysis of Biosimilar Insulin
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Biosimilar Insulin Market Size by Big Type
Figure Global Market Share of Biosimilar Insulin by Big Type in 2021
Figure Rapid Acting Insulins Picture (2017-2022)
Figure Short Acting Insulins Picture (2017-2022)
Figure Intermediate Insulins Picture (2017-2022)
Global Biosimilar Insulin Market Size by Big Application
Table Global Biosimilar Insulin Market Size by Application
Figure Global Biosimilar Insulin Market Share by Big Application in 2021
Figure Hospital Picture
Figure Clinic Picture
Figure Medical Center Picture
Table Global Biosimilar Insulin Comparison by Regions (M USD) (2017-2027)
Figure Global Biosimilar Insulin Market Size (Million US$) (2017-2027)
Figure North America Biosimilar Insulin Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Biosimilar Insulin Revenue (Million US$) Growth Rate (2017-2027)
Figure China Biosimilar Insulin Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Biosimilar Insulin Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Biosimilar Insulin Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Biosimilar Insulin Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Biosimilar Insulin Sales by Manufacturer (2017-2022)
Figure Global Biosimilar Insulin Sales Market Share by Manufacturer in 2021
Table Global Biosimilar Insulin Revenue by Manufacturer (2017-2022)
Figure Global Biosimilar Insulin Revenue Market Share by Manufacturer in 2021
Table Global Biosimilar Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Biosimilar Insulin Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Biosimilar Insulin Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Biosimilar Insulin Market
Table Key Manufacturers Biosimilar Insulin Product Type
Table Mergers & Acquisitions Planning
Table Pfizer Company Profile
Table Biosimilar Insulin Product Introduction, Application and Specification of Pfizer
Table Biosimilar Insulin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Biogenomics Company Profile
Table Biosimilar Insulin Product Introduction, Application and Specification of Biogenomics
Table Biosimilar Insulin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biogenomics Recent Development
Table Eli Lilly Company Profile
Table Biosimilar Insulin Product Introduction, Application and Specification of Eli Lilly
Table Biosimilar Insulin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Gan&Lee Pharmaceuticals Company Profile
Table Biosimilar Insulin Product Introduction, Application and Specification of Gan&Lee Pharmaceuticals
Table Biosimilar Insulin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Gan&Lee Pharmaceuticals Main Business
Table Gan&Lee Pharmaceuticals Recent Development
Table Gan&Lee Pharmaceuticals Main Business
Table Gan&Lee Pharmaceuticals Recent Development
Table Geropharm Company Profile
Table Biosimilar Insulin Product Introduction, Application and Specification of Geropharm
Table Biosimilar Insulin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Geropharm Main Business
Table Geropharm Recent Development
Table Julphar Gulf Pharmaceutical Industries Company Profile
Table Biosimilar Insulin Product Introduction, Application and Specification of Julphar Gulf Pharmaceutical Industries
Table Biosimilar Insulin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Julphar Gulf Pharmaceutical Industries Main Business
Table Julphar Gulf Pharmaceutical Industries Recent Development
Table Paras Biopharmaceuticals Company Profile
Table Biosimilar Insulin Product Introduction, Application and Specification of Paras Biopharmaceuticals
Table Biosimilar Insulin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Paras Biopharmaceuticals Main Business
Table Paras Biopharmaceuticals Recent Development
Table Samsung Bioepis Company Profile
Table Biosimilar Insulin Product Introduction, Application and Specification of Samsung Bioepis
Table Biosimilar Insulin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Samsung Bioepis Main Business
Table Samsung Bioepis Recent Development
Table Sedico Company Profile
Table Biosimilar Insulin Product Introduction, Application and Specification of Sedico
Table Biosimilar Insulin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sedico Main Business
Table Sedico Recent Development
Table Wockhardt Company Profile
Table Biosimilar Insulin Product Introduction, Application and Specification of Wockhardt
Table Biosimilar Insulin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Wockhardt Main Business
Table Wockhardt Recent Development
Table Teva Pharmaceuticals Company Profile
Table Biosimilar Insulin Product Introduction, Application and Specification of Teva Pharmaceuticals
Table Biosimilar Insulin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Pharmaceuticals Main Business
Table Teva Pharmaceuticals Recent Development
Figure Global Biosimilar Insulin Sales and Growth Rate (2017-2022)
Figure Global Biosimilar Insulin Revenue and Growth Rate (2017-2022)
Table Global Biosimilar Insulin Sales by Regions (2017-2022)
Figure Global Biosimilar Insulin Sales Market Share by Regions in 2021
Table Global Biosimilar Insulin Revenue by Regions (2017-2022)
Figure Global Biosimilar Insulin Revenue Market Share by Regions in 2021
Figure North America Biosimilar Insulin Sales and Growth Rate (2017-2022)
Figure Europe Biosimilar Insulin Sales and Growth Rate (2017-2022)
Figure China Biosimilar Insulin Sales and Growth Rate (2017-2022)
Figure Japan Biosimilar Insulin Sales and Growth Rate (2017-2022)
Figure Southeast Asia Biosimilar Insulin Sales and Growth Rate (2017-2022)
Figure Other Regions Biosimilar Insulin Sales and Growth Rate (2017-2022)
Table Global Biosimilar Insulin Sales by Big Type (2017-2022)
Table Global Biosimilar Insulin Sales Market Share by Big Type (2017-2022)
Figure Global Biosimilar Insulin Sales Market Share by Big Type in 2019
Table Global Biosimilar Insulin Revenue by Big Type (2017-2022)
Table Global Biosimilar Insulin Revenue Market Share by Big Type (2017-2022)
Table Global Biosimilar Insulin Revenue Market Share by Big Type in 2019
Figure Global Rapid Acting Insulins Sales Growth Rate (2017-2022)
Figure Global Rapid Acting Insulins Price (2017-2022)
Figure Global Short Acting Insulins Sales Growth Rate (2017-2022)
Figure Global Short Acting Insulins Price (2017-2022)
Figure Global Intermediate Insulins Sales Growth Rate (2017-2022)
Figure Global Intermediate Insulins Price (2017-2022)
Figure Global Long Lasting Insulins Sales Growth Rate (2017-2022)
Table Global Biosimilar Insulin Sales by Big Application (2017-2022)
Table Global Biosimilar Insulin Sales Market Share by Big Application (2017-2022)
Figure Global Biosimilar Insulin Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Medical Center Sales Growth Rate (2017-2022)
Figure Global Biosimilar Insulin Sales and Growth Rate (2022-2027)
Figure Global Biosimilar Insulin Revenue and Growth Rate (2022-2027)
Table Global Biosimilar Insulin Sales Forecast by Regions (2022-2027)
Table Global Biosimilar Insulin Market Share Forecast by Regions (2022-2027)
Figure North America Sales Biosimilar Insulin Market Forecast (2022-2027)
Figure Europe Sales Biosimilar Insulin Market Forecast (2022-2027)
Figure China Sales Biosimilar Insulin Market Forecast (2022-2027)
Figure Japan Sales Biosimilar Insulin Market Forecast (2022-2027)
Figure Southeast Asia Sales Biosimilar Insulin Market Forecast (2022-2027)
Figure Other Regions Sales Biosimilar Insulin Market Forecast (2022-2027)
Table Global Biosimilar Insulin Sales Forecast by Type (2022-2027)
Table Global Biosimilar Insulin Market Share Forecast by Type (2022-2027)
Table Global Biosimilar Insulin Sales Forecast by Application (2022-2027)
Table Global Biosimilar Insulin Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Insulin
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Biosimilar Insulin Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Biosimilar Insulin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Biosimilar Insulin Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Biosimilar Insulin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Biosimilar Insulin Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Biosimilar Insulin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Biosimilar Insulin Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Biosimilar Insulin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Pfizer
Biogenomics
Eli Lilly
Gan&Lee Pharmaceuticals
Geropharm
Julphar Gulf Pharmaceutical Industries
Paras Biopharmaceuticals
Samsung Bioepis
Sedico
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)